Volume 67, Pages S15-S19 (January 2005)

Slides:

Advertisements

Similar presentations

Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis Giuseppe D’Amico Kidney International Volume 54, Issue 2, Pages

Advertisements

Peritoneal transport assessment by peritoneal equilibration test with 3.86% glucose: A long-term prospective evaluation V. La Milia, P. Pozzoni, G. Virga,

Epidemiology of end-stage renal disease: International comparisons of renal replacement therapy Francesco Paolo Schena Kidney International Volume 57,

Chapter 1: Definition and classification of CKD Kidney International Supplements Volume 3, Issue 1, Pages (January 2013) DOI: /kisup

A.M. Thompson, T.G. Pickering Kidney International

MariLia Bahiense Oliveira, Joao Egidio Romao, Roberto Zatz

Anemia management in chronic kidney disease

Mitchell H. Rosner, W. Kline Bolton Kidney International

Volume 83, Issue 3, Pages (March 2013)

End-stage renal disease prevention strategies in Latin America

Francesco Locatelli, Lucia Del Vecchio, Simeone Andrulli, Sara Colzani

Volume 69, Issue 5, Pages (March 2006)

Membranous nephropathy: When and how to treat

Prehypertension and chronic kidney disease: the ox or the plow?

Progression of renal failure and hypertensive nephrosclerosis

Volume 77, Issue 1, Pages 6-8 (January 2010)

Haiyan Wang, Luxia Zhang, Jicheng Lv Kidney International

Francesco Paolo Schena Kidney International

Response to is the reduction in urea distribution volume over time in clinically stable dialysis patients real? S. Andrulli, S. Di Filippo, F. Locatelli

Volume 69, Pages S11-S15 (April 2006)

Volume 70, Pages S21-S25 (December 2006)

Volume 68, Issue 5, Pages (November 2005)

Homocysteine and risk in end-stage renal disease: a matter of context

Volume 69, Issue 2, Pages (January 2006)

Volume 53, Issue 4, Pages (April 1998)

Comorbidity and confounding in end-stage renal disease

Volume 74, Issue 3, Pages (August 2008)

Volume 70, Issue 11, Pages (December 2006)

Joseph W. Eschbach, John W. Adamson Kidney International

Patient selection affects end-stage renal disease outcome comparisons

Gary C.W. Chan, Sydney C.W. Tang Kidney International

The epidemiology of chronic kidney disease

Achieving blood pressure targets during dialysis improves control but increases intradialytic hypotension A. Davenport, C. Cox, R. Thuraisingham Kidney.

Study of Heart and Renal Protection (SHARP)

Volume 73, Pages S5-S17 (April 2008)

Blood pressure targets in hemodialysis patients

Volume 76, Issue 5, Pages (September 2009)

Volume 67, Pages S63-S68 (January 2005)

Fructose intake as a risk factor for kidney stone disease

Volume 76, Issue 6, Pages (September 2009)

Volume 68, Issue 2, Pages (August 2005)

Francesco Locatelli, Lucia Del Vecchio Kidney International

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Nephrology in Latin America, with special emphasis on Brazil

Volume 69, Issue 4, Pages (February 2006)

Methods for guideline development

Juan M. Lopez-Gomez, Eduardo Verde, Rafael Perez-Garcia

Volume 87, Issue 1, Pages (January 2015)

Volume 85, Issue 1, Pages 3-4 (January 2014)

Counteracting progression of renal disease: A look into the future

Volume 62, Issue 4, Pages (October 2002)

Volume 56, Issue 5, Pages (November 1999)

Volume 67, Pages S55-S62 (January 2005)

Opportunities for a chronic disease outreach program in China

Phosphate binders on iron basis: A new perspective?

Volume 66, Issue 2, Pages (August 2004)

Clinical benefits of slowing the progression of renal failure

Volume 70, Pages S84-S90 (November 2006)

Atherosclerotic nephropathy

Early detection and prevention of diabetic nephropathy: A challenge calling for mandatory action for Mexico and the developing world Ricardo Correa-Rotter,

Volume 80, Issue 10, Pages (November 2011)

Is it the low-protein diet or simply the salt restriction?

Charles A. Herzog Kidney International

Volume 75, Issue 1, Pages (January 2009)

Evaluation of the Losartan in Hemodialysis (ELHE) Study

Renal vascular disease in the elderly

Volume 58, Issue 5, Pages (November 2000)

Kidney and hypertension

Stephen Pastan, J. Michael Soucie, William M. McClellan

Presentation transcript:

Volume 67, Pages S15-S19 (January 2005) Is it the agent or the blood pressure level that matters for renal and vascular protection in chronic nephropathies? Francesco Locatelli, Lucia Del Vecchio, Pietro Pozzoni, Marco D'Amico, Simeone Andrulli Kidney International Volume 67, Pages S15-S19 (January 2005) DOI: 10.1111/j.1523-1755.2005.09304.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 MAP distribution during follow-up in the low and usual blood pressure groups of the MDRD study18.This estimate has been obtained assuming a Gaussian distribution of BP values during follow-up (considering the high number of patients). We then calculated from the characteristics of normal distributions the percentage of patients with MAP values higher than the threshold of 97mm Hg (equivalent to 130/80mm Hg), 101mm Hg (equivalent to 135/85mm Hg), and 107mm Hg (equivalent to 140/90mm Hg), respectively. Kidney International 2005 67, S15-S19DOI: (10.1111/j.1523-1755.2005.09304.x) Copyright © 2005 International Society of Nephrology Terms and Conditions